Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Synapse density refers to the number of synaptic connections per unit volume in neural tissue, commonly quantified in regions of the brain to assess neural network connectivity, plasticity, and health. It fluctuates throughout development, peaking in early life, followed by pruning to reach stable adult values. Changes in synapse density—loss in aging, neurodegeneration, or abnormal development—correlate with cognitive capacity and are a sensitive indicator of brain health. Synapse density is not a molecule or receptor, so it is not directly targeted by drugs, but is an important feature measured in neuroscience and pathology as a biomarker for various diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synapse density.